Open access
Open access
Powered by Google Translator Translator

Wed June 26 – 10 Stories of The Day!

26 Jun, 2019 | 08:00h | UTC

 

1 – Hypertension in pregnancy: diagnosis and management – National Institute for Health and Care Excellence (free)

Related Guidelines: WHO recommendations: Drug treatment for severe hypertension in pregnancy – World Health Organization (free) AND Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy (free)

Related Reviews: State-of-the-Art Diagnosis and Treatment of Hypertension in Pregnancy – Mayo Clinic Proceedings (free) AND Hypertension in pregnancy: Pathophysiology and treatment – SAGE Open Medicine (free)

 

2 – Depression in children and young people: identification and management – National Institute for Health and Care Excellence (free)

Related: AAP Guidelines for Adolescent Depression in Primary Care (free)

 

3 – Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality – JAMA (free for a limited period)

Editorial: Accuracy of Airflow Obstruction Thresholds for Predicting COPD-Related Hospitalization and Mortality: Can Simple Diagnostic Thresholds Be Used for a Complex Disease? (free)

Commentary: Study funded by NIH supports optimal threshold for diagnosing COPD – NIH News Releases (free)

“These results support the use of FEV1:FVC less than 0.70 to identify individuals at risk of clinically significant COPD.”

 

4 – Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial – JAMA (free for a limited period)

Related Study: Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Dual Antiplatelet Therapy: Is It Time to Cut the Cord With Aspirin? (free for a limited period)

Audio Summary: Reducing the Intensity of Antithrombotic Therapy Following Coronary Stent Procedures (free)

Commentaries: Shorter Dual Antiplatelet Therapy May Be an Option for Patients Undergoing PCI – NEJM Journal Watch (free) AND Short and Optimal Duration of Dual Antiplatelet Therapy After Everolimus-Eluting Cobalt-Chromium Stent-2 – STOPDAPT-2 – American College of Cardiology (free)

 

5 – Did This Patient Have Cardiac Syncope? The Rational Clinical Examination Systematic Review – JAMA (free for a limited period)

Related Guidelines: 2018 ESC Guidelines for the diagnosis and management of syncope – European Heart Journal (free) AND 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope (free)

 

6 – Choosing Wisely: Case Studies from the Top 10 Recommendations Across Campaigns – The Commonwealth Fund (free case studies)

See complete lists of low-value practices: Choosing Wisely U.S. / Choosing Wisely UK / Choosing Wisely Australia AND Choosing Wisely Canada

 

7 – Incidence of New Onset Diabetes Mellitus Secondary to Acute Pancreatitis: A Systematic Review and Meta-Analysis – Frontiers in Physiology (free)

 

8 – Alex Nowbar’s journal reviews, 25 June 2019 – The BMJ Opinion (free)

Alex Nowbar reviews the latest research from the top medical journals.

 

9 – Risk of ESKD in Older Live Kidney Donors with Hypertension – Clinical Journal of the American Society of Nephrology (link to abstract – $ for full-text)

Commentary: Higher Risk of Kidney Failure in Older Donors With Hypertension – Medscape (free registration required)

 

10 – Cognitive Decline Before and After Incident Coronary Events – Journal of the American College of Cardiology (free)

Commentaries: Cognitive decline may accelerate after heart attack, angina – American College of Cardiology (free) AND Ischemic Events Worsen Long-term Cognitive Decline – TCTMD (free) AND Heart problems may hasten cognitive decline – Reuters (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.